Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy Full Text
Journal of the American Society of Nephrology,  Clinical Article

Kohan DE et al. - Atrasentan, at the doses tested i.e. 0.25, 0.75, or 1.75 mg daily, is generally safe and effective in reducing residual albuminuria and may ultimately improve renal outcomes in patients with type 2 diabetic nephropathy.

Methods
  • Authors examined the effect of atrasentan, a selective endothelin A receptor (ETAR) antagonist, on albuminuria.
  • This is a randomized, double-blind, placebo-controlled trial of subjects with diabetic nephropathy already receiving stable doses of renin-angiotensin system (RAS) inhibitors.
  • 89 subjects with eGFR >20 ml/min per 1.73 m2 and a urinary albumin-to-creatinine ratio (UACR) of 100 to 3000 mg/g to placebo or atrasentan (0.25, 0.75, or 1.75 mg daily) for 8 weeks were assigned.

Results
  • Compared with placebo, atrasentan significantly reduced urinary albumin-to-creatinine ratio (UACR) only in the 0.75- and 1.75-mg groups (P = 0.001 and P = 0.011, respectively).
  • Compared with the 11% reduction in the geometric mean of the UACR from baseline to final observation in the placebo group during the study, the geometric mean of UACR decreased by 21, 42, and 35% in the 0.25-, 0.75-, and 1.75-mg atrasentan groups (P = 0.291, P = 0.023, and P = 0.073, respectively).
  • In the placebo group, 17% of subjects achieved >=40% reduction in UACR from baseline compared with 30, 50, and 38% in the 0.25-, 0.75-, and 1.75-mg atrasentan groups, respectively (P = 0.029 for 0.75 mg versus placebo).
  • Peripheral edema occurred in 9% of subjects receiving placebo and in 14, 18, and 46% of those receiving 0.25, 0.5, and 1.75 mg atrasentan, respectively (P = 0.007 for 1.75 mg versus placebo).

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

2 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

3 Tonsillectomy for IgA nephropathy: A meta-analysis American Journal of Kidney Diseases, October 29, 2014    Evidence Based Medicine

4 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

5 High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: The chronic renal insufficiency cohort (CRIC) study Journal of the American Society of Nephrology, October 8, 2014    Clinical Article

6 Medications associated with restless legs syndrome: a case–control study in the US Renal Data System (USRDS) Sleep Medicine, October 8, 2014    Clinical Article

7 Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: A meta-analysis of randomized controlled trials European Journal of Cardio-Thoracic Surgery, October 24, 2014    Evidence Based Medicine    Review Article

8 ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010 American Journal of Kidney Diseases, August 18, 2014    Clinical Article

9 Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis Pediatric Nephrology, September 25, 2014    Clinical Article

10 Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients Therapeutic Apheresis and Dialysis, September 15, 2014    Clinical Article

11 Daily protein intake and patient outcomes in severe acute kidney injury: Findings of the randomized evaluation of normal versus augmented level of replacement therapy (RENAL) trial Blood Purification, September 4, 2014    Clinical Article

12 Heparin use in hemodialysis patients following gastrointestinal bleeding American Journal of Nephrology, October 20, 2014    Clinical Article

13 A meta-analysis of stent placement vs. angioplasty for dialysis vascular access stenosis Seminars in Dialysis, October 13, 2014    Evidence Based Medicine    Clinical Article

14 Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: A meta-analysis of 19 studies American Journal of Nephrology, October 15, 2014    Evidence Based Medicine    Review Article

15 Rituximab treatment for fibrillary glomerulonephritis Nephrology Dialysis Transplantation, October 1, 2014    Clinical Article

16 The changing landscape of home dialysis in the United States Current Opinion in Nephrology and Hypertension, October 14, 2014    Review Article

17 Body mass index and mortality in kidney transplant recipients: A systematic review and meta-analysis American Journal of Nephrology, October 21, 2014    Evidence Based Medicine    Review Article

18 The role of statins in preventing contrast-induced acute kidney injury: a narrative review Angiology, September 17, 2014    Review Article    Clinical Article

19 Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors Clinical Journal of the American Society of Nephrology, October 17, 2014    Clinical Article

20 The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis QJM: An International Journal of Medicine, October 2, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore